Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
fantastic people, great benefits, remote environment, patient focused, noble mission, bring your dog to work, growth and opportunities
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
transparent, care about employees, smart and passionate, inspiring
Qu’est-ce qui vous rend le plus heureux au travail?
the people, the entrepreneurial work,
Quelle est la meilleure partie de votre programme de rémunération?
generous bonus and opportunity to earn more stock based on performance
Quelles sont les meilleures choses à propos de votre équipe?
collaborative, mission focused, willing to do what it takes, smart and fun
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
focus on DEI, community week events bring teams and people together, transparent communications, celebrating successes and people, focus on people first
Other Employee Reviews for Karyopharm Therapeutics
×